Skip to content
MeiLuft

Applications

The vision was born during the coronavirus pandemic: to see pathogens directly instead of detecting them through elaborate tests. It has grown into a platform for nanoparticles – one hardware platform, many applications.

≈ 200 nmLimit of the light microscope. Viruses, ultrafine dust and nanoplastics are often smaller.Diffraction limit for visible light
≈ 100 nmSize of a typical virus – visible only in an electron microscope.Order of magnitude
≈ 5 millionDeaths per year worldwide associated with antibiotic-resistant bacteria.Estimate for 2019, GRAM study, The Lancet 2022

One platform

Today, particles below 200 nanometres can only be imaged in specialised laboratories: in a vacuum, after elaborate preparation, usually for a single question. Our microscope measures in air and analyses the results itself. The applications differ mainly in software, particle material and regulatory effort – which is why we start where no approval is needed.

Industry

Particles in manufacturing: abrasion from metals and brakes, contamination in semiconductor and battery processes. Seeing every particle individually reveals, from its shape and material, where it comes from – so that the source can be eliminated.

Industrial applications require no regulatory approval. That is why they come first.

Freshly machined metal part with fine metal dust on a workbench
Illustration, AI-generated

Ultrafine dust in the air

Ultrafine dust from traffic, combustion and industry penetrates deep into the lungs and bloodstream. Common instruments count particles or determine their mass – they do not see which particles they are. An imaging measurement shows particles individually rather than averages and adds the question of their origin to today’s methods.

Haze over a street in the morning light
Illustration, AI-generated

Nanoplastics in water

Plastic breaks down into ever smaller particles. Nanoplastics enter the body through drinking water, food and air. Measuring their concentration is laborious with today’s analytical methods. Because our sample can also remain in liquid, the aim is to image plastic particles individually and tell them apart from other particles.

Water sample against the light
Illustration, AI-generated

Medicine, in the long term

In a severe infection such as sepsis, every hour counts. The usual diagnosis via cultures often takes several days; until then, broad-spectrum antibiotics are frequently given, which promote the development of resistant pathogens. Worldwide, around five million deaths each year are associated with antibiotic-resistant bacteria (estimate for 2019).

Bacteria themselves are large enough for the light microscope. There, however, they only appear as rods or spheres of about one micrometre; after staining they can be roughly sorted into groups, but which species it is usually only becomes clear after growing them in culture. The electron microscope shows shape and surface in detail. How far pathogens can be told apart by these features is something we want to investigate with the prototype.

Our long-term goal: recognising pathogens directly in the sample. This is a goal that requires regulatory approval, not a current offering.

Emergency department at night
Illustration, AI-generated

Research

For universities and laboratories, a compact electron microscope that measures in air and analyses the results itself is a tool for series of investigations that have so far been tied to large instruments and elaborate sample preparation.

For investors

Approach
Compact scanning electron microscope that measures in air through a window; our own hardware right down to the beam; a physical model of the instrument
Physical AI
AI that improves images, recognises particles and runs the microscope itself
Markets
In stages: industry without regulatory approval first, then the environment, medicine in the long term
Status
Beam system tested, test microscope with our own control system delivers first images, prototype under construction – where we stand
Intellectual property
Our own patents on imaging and detecting particles
Funding
Research allowance: positive decision by the BSFZ for a first sub-project
Needs
Funding for the prototype and the first application studies

We are happy to present our progress to you in a meeting and in our laboratory: durchatmen@meiluft.de.